Results 181 to 190 of about 56,774 (264)

Explaining the Insights Obtained from the BRANDO Database. [PDF]

Arq Neuropsiquiatr
Berger JR, Pisano T.
europepmc   +1 more source

Factors associated with the progression of disability (EDSS) among MS patients. [PDF]

eNeurologicalSci
Arteaga-Noriega A, Zapata-Berruecos J, Gutiérrez-Vargas J, Garcia JC, Rojas-Gualdron D, Restrepo-Botero M.   +5 more
europepmc   +1 more source

Association of Brain Age With Physical Disability and Cognitive Impairment in People With Multiple Sclerosis of the Same Age. [PDF]

Neurology
Bos L, Wink AM, Cole JH, Strijbis EMM, Moraal B, Killestein J, Vrenken H, Uitdehaag BMJ, Barkhof F, Schoonheim MM, Jasperse B.   +10 more
europepmc   +1 more source

Severe Late-Onset Neutropenia in a Patient With Multiple Sclerosis Treated With Ocrelizumab. [PDF]

Cureus
Mansour MK, Raghunathan R, Mohamed A, Ahmed H, Hassan Y.   +4 more
europepmc   +1 more source

Selected Serum Biomarkers in Patients with Relapsing-Remitting Multiple Sclerosis-A 3-Year Prospective Pilot Study. [PDF]

Med Sci (Basel)
Puz P, Maciejowska K, Gendosz de Carrillo D, Janik M, Lasek-Bal A.   +4 more
europepmc   +1 more source

Extracellular Vesicle-Derived microRNAs as Fluid Biomarkers in Neurodegenerative Diseases: A Systematic Review. [PDF]

J Neurochem
Zaman A, Drake SS, Fournier AE.
europepmc   +1 more source

Correction: Characteristics and correlations of sleep disorders in patients with relapsing-remitting multiple sclerosis in China: a cross-sectional study. [PDF]

Front Neurol
Wang R, Zhang T, Wang H, Ren Y, Zhao R, Zhang G, Zhang G, Zhao X.   +7 more
europepmc   +1 more source

Balancing innovation and affordability in relapsing-remitting multiple sclerosis: a budget impact analysis from Saudi Arabia. [PDF]

Front Public Health
Al-Jedai A, Almudaiheem H, Al-Suweidan F, Jumah MA, Al-Thobaiti A, Alzureiqan F, Abu Ras W, Al-Dosari FM, Malik YA, Dhopte P, Ojeil R.   +10 more
europepmc   +1 more source

Effectiveness of teriflunomide in patients with relapsing multiple sclerosis who switched from other disease-modifying therapies. [PDF]

Medicine (Baltimore)
Berkovich R, Greene N, Reddy SR, Chang E, Tarbox MH, Fadaee S, Quach C, Pyatkevich Y.   +7 more
europepmc   +1 more source